Prostate cancer
Results
Phase 2
This trial was looking at high intensity focused ultrasound (HIFU) for localised prostate cancer.
Doctors can treat localised prostate cancer with surgery or radiotherapy. But both of these can cause side effects such as urinary problems, difficulty getting an erection (impotence) and bowel problems including diarrhoea.
Doctors have been looking at a treatment called high intensity focused ultrasound or HIFU which they hoped would cause fewer side effects. High intensity ultrasound beams can kill cancer cells if the beam is focused directly onto them using a special machine.
In this trial, the doctors used HIFU for prostate cancers that were completely within the prostate gland. Rather than treating the whole of the prostate gland, the doctors only treated the areas that contained cancer. This is called focal ablation treatment.
The main aim of the trial was to learn more about the side effects of focal ablation using HIFU.
Recruitment start: 27 June 2007
Recruitment end: 30 June 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Mark Emberton Hashim Ahmed
Medical Research Council (MRC)
National Institute for Health Research Cancer Research Network (NCRN)
Pelican Cancer Foundation
St Peters Trust
University College London Hospitals NHS Foundation Trust
Last reviewed: 30 April 2012
CRUK internal database number: 1091